Protagenic Therapeutics, Inc.\new Income (Loss) Attributable to Noncontrolling Interest, before Tax
Protagenic Therapeutics, Inc.\new (PTIX) reported Income (Loss) Attributable to Noncontrolling Interest, before Tax of -$6.00 thousand for the 6-month period ending 2015-12-31, per its 10-Q filed 2016-03-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossAttributableToNoncontrollingInterest · last filed 2016-03-11
- 2015-12-31: Income (Loss) Attributable to Noncontrolling Interest, before Tax 6 month -$6.00K.
- 2014-12-31: Income (Loss) Attributable to Noncontrolling Interest, before Tax 6 month -$13.00K.
| Period end | Income (Loss) Attributable to Noncontrolling Interest, before Tax 6 month |
|---|---|
| 2015-12-31 | -$6.00K 10-Q · filed 2016-03-11 |
| 2014-12-31 | -$13.00K 10-Q · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |